BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 122 filers reported holding BRIDGEBIO PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,406,000 | -70.3% | 30,000 | -61.3% | 0.18% | -55.6% |
| Q2 2021 | $4,730,000 | -8.4% | 77,600 | -7.4% | 0.41% | -27.6% |
| Q1 2021 | $5,162,000 | +476.1% | 83,801 | +565.1% | 0.57% | +439.0% |
| Q4 2020 | $896,000 | +89.4% | 12,600 | 0.0% | 0.10% | +50.0% |
| Q3 2020 | $473,000 | +15.1% | 12,600 | 0.0% | 0.07% | -48.9% |
| Q2 2020 | $411,000 | -21.3% | 12,600 | -30.0% | 0.14% | -43.9% |
| Q1 2020 | $522,000 | -17.3% | 18,000 | 0.0% | 0.24% | -36.1% |
| Q4 2019 | $631,000 | -36.8% | 18,000 | -61.3% | 0.38% | -27.7% |
| Q3 2019 | $999,000 | -38.3% | 46,548 | -22.4% | 0.53% | +47.1% |
| Q2 2019 | $1,618,000 | – | 60,000 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $373,797,000 | 67.28% |
| Darwin Global Management, Ltd. | 2,090,149 | $128,753,000 | 25.21% |
| Affinity Asset Advisors, LLC | 577,500 | $35,574,000 | 12.08% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $1,913,356,000 | 9.64% |
| Perceptive Advisors | 7,756,928 | $477,827,000 | 6.04% |
| Opaleye Management Inc. | 583,767 | $35,960,000 | 5.28% |
| MIZUHO MARKETS AMERICAS LLC | 171,923 | $10,590,000 | 4.93% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $1,639,853,000 | 4.88% |
| Fernwood Investment Management, LLC | 151,085 | $9,307,000 | 3.42% |
| HHLR ADVISORS, LTD. | 5,362,014 | $330,300,000 | 3.26% |